Drug | KO-539 | SNDX 5613 |
---|---|---|
Tumor type | Advanced malignant neoplasm; Acute myeloid leukemia; Mixed lineage leukemia; Mixed lineage acute leukemia; Acute leukemia of ambiguous lineage; Mixed phenotype acute leukemia | Acute myeloid leukemia; Acute lymphoblastic leukemia; Mixed lineage acute leukemia; Mixed phenotype acute leukemia; Acute leukemia of ambiguous lineage |
Phase | Phase 1, Phase 2 | Phase 1, Phase 2 |
Clinical efficacy | Not released | Not released |
Safety (% patients) | Not released | Not released |
Trial number | NCT04067336 | NCT04065399 |
Status | Recruiting | Recruiting |